The move is the latest recruiting win for RBC Wealth Management as it continues to lure top talent away from big banks and ...

J.P.Morgan estimated spending on data centers could contribute between 10-20 basis points to U.S. economic growth in ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

Jamie Dimon, chairman and CEO, noted in the release that in the asset and wealth management division client net inflows ...

The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...

LOTTE BIOLOGICS (CEO James Park) announced on January 16 that it had presented at the "Asia-Pacific (APAC)" track of the J.P.

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...

More than 8,000 healthcare professionals will descend on San Francisco starting Monday for the 43rd annual J.P. Morgan ...

Winning with a top-flight investment framework. Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers, over a ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...